Gerresheimer AG (ETR:GXI) has received an average recommendation of “Hold” from the nine analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is €79.80 ($93.88).

A number of analysts have weighed in on the company. Commerzbank Ag set a €73.00 ($85.88) price target on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, July 13th. DZ Bank AG restated a “neutral” rating on shares of Gerresheimer AG in a research note on Friday, June 9th. Hauck & Aufhaeuser set a €80.00 ($94.12) price target on Gerresheimer AG and gave the company a “neutral” rating in a research note on Friday, July 14th. Kepler Capital Markets set a €70.00 ($82.35) target price on Gerresheimer AG and gave the stock a “sell” rating in a research report on Thursday, July 13th. Finally, Berenberg Bank set a €83.00 ($97.65) target price on Gerresheimer AG and gave the stock a “buy” rating in a research report on Thursday, June 15th.

Shares of Gerresheimer AG (GXI) traded down 0.162% on Friday, reaching €69.188. The company had a trading volume of 100 shares. Gerresheimer AG has a 52 week low of €64.00 and a 52 week high of €79.47. The company has a market capitalization of €2.17 billion and a P/E ratio of 19.166. The company has a 50 day moving average of €71.04 and a 200-day moving average of €73.13.

COPYRIGHT VIOLATION WARNING: “Gerresheimer AG (GXI) Receives €82.16 Average Price Target from Analysts” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/07/gerresheimer-ag-gxi-receives-82-16-consensus-target-price-from-brokerages-updated-updated-updated.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Stock Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related stocks with our FREE daily email newsletter.